Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
KYTHERA BIOPHARMACEUTICALS INC (KYTH)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-15 | Mar-31-15 | Dec-31-14 | Sep-30-14 | Jun-30-14 | Mar-31-14 | Dec-31-13 | Sep-30-13 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 100.0% | | 100.0% | | | | 100.0% | |
| Cost of goods sold | 4.9% | | 0.0% | | | | 0.0% | |
| Gross profit | 95.1% | | 100.0% | | | | 100.0% | |
| Selling, general and administrative | 8672.2% | | | | | | | |
| Research and development | 3898.3% | | 10.2% | | | | 18.2% | |
| General and administrative | | | 7.3% | | | | 8.6% | |
| Depreciation | 67.0% | | 0.1% | | | | 0.1% | |
| EBIT | -12475.3% | | -17.5% | | | | -26.9% | |
| Pre-tax income | -12900.7% | | -18.3% | | | | -27.8% | |
| Income taxes | 0.0% | | 0.0% | | | | 0.0% | |
| Net income | -12900.7% | | -18.3% | | | | -27.8% | |
|